By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...

Man with deadly glioblastoma shows no signs of disease after taking experimental immunotherapy drug ipilimumab, inspiring a ...

Replimune faces FDA hurdles for RP1, an innovative melanoma treatment, as it seeks a path forward after receiving a complete ...

In a devastating turn of event, 40-year-old Ben Trotman was being diagnosed with the deadlist form of brain cancer in 2022, ...

Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...

The 81,000-square-foot facility will enhance the health system's cancer care offerings in the UK, with completion expected in ...

SCOPE is testing administration of intramuscular SCIB1 and intradermal iSCIB1+, which codes for various melanoma antigens ...

Interleukin-18 (IL-18) is a pro-inflammatory cytokine that plays a crucial role in promoting antitumor immunity by activating T and natural killer (NK) cells. However, the therapeutic use of wild-type ...

Our research, if it is successful, then we will develop a new immunotherapy, so the next step will be a clinical trial,” said MSU professor Dohun Pyeon.